Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA · Entity 7752 | Director | July 06, 2026 | July 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date July 06, 2026 · Filed July 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.20 · Expires 2036-07-06 | Direct | 23,573 |
Reported balance
After 2026-07-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-06 · Grant · Acquired 8,000 · Balance 23,573 F1: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2018 Filed Dec 3, 2018 21:01 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $2.10 | $2,102.00 |
DisclosureSEC source: 0001437749-18-021494 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Read SEC document |
| November 14, 2018 Filed Nov 17, 2018 01:22 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $2.14 | $2,140.50 |
DisclosureSEC source: 0001437749-18-021033 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| November 13, 2018 Filed Nov 13, 2018 23:39 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $2.10 | $2,100.00 |
DisclosureSEC source: 0001437749-18-020640 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| November 02, 2018 Filed Nov 7, 2018 02:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 2,000 | $2.53 | $5,060.00 |
DisclosureSEC source: 0001437749-18-019719 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| October 11, 2018 Filed Oct 12, 2018 10:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $2.70 | $2,700.00 |
DisclosureSEC source: 0001437749-18-018211 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 01:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $2.43 | $2,430.00 |
DisclosureSEC source: 0001437749-18-017391 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,609,609 F1 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 23:44 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,000 | $1.50 | $7,500.00 |
DisclosureSEC source: 0001437749-18-017267 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,608,609 F1 · price: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. F1 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| September 18, 2018 Filed Sep 26, 2018 20:51 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,000 | $1.50 | $7,500.00 |
DisclosureSEC source: 0001437749-18-017489 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,616,609 F1 · price: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. F2 · balance_after: The amount of securities beneficially held following the reported transaction was incorrectly reported in the Form 4 filed on September 20, 2018. The corrected amount is now correctly reported herein. F1 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| July 26, 2018 Filed Sep 27, 2018 01:17 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantRestricted Stock Units · Derivative | 32,353 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-017511 · rdgdoc.xml · derivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,353 Underlying: Common Stock · 32,353 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest as to one hundred percent of the shares on July 26, 2019, subject to the Reporting Person continuing as a service provider through such date. Vested shares will be delivered to the Reporting Person on July 26, 2019 F2 · derivative.expiration_date: The restricted stock units vest as to one hundred percent of the shares on July 26, 2019, subject to the Reporting Person continuing as a service provider through such date. Vested shares will be delivered to the Reporting Person on July 26, 2019 Read SEC document |
| March 26, 2018 Filed Mar 27, 2018 01:55 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 8,000 | $1.87 | $14,960.00 |
DisclosureSEC source: 0001437749-18-005521 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,611,609 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.88 to $1.91 for the March 23, 2018 purchases and $1.85 to $1.90 for the March 26, 2018 purchases; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the Registrant, or a security holder of the Registrant. F2 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 01:55 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 10,000 | $1.90 | $19,000.00 |
DisclosureSEC source: 0001437749-18-005521 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,603,609 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.88 to $1.91 for the March 23, 2018 purchases and $1.85 to $1.90 for the March 26, 2018 purchases; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the Registrant, or a security holder of the Registrant. F2 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| March 22, 2018 Filed Mar 23, 2018 01:48 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 3,000 | $1.87 | $5,610.00 |
DisclosureSEC source: 0001437749-18-005273 · rdgdoc.xml · nonDerivative · entry 2 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,593,608 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.90 to $1.94 for the March 21, 2018 purchases and $1.85 to $1.90 for the March 22, 2018 purchases; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the Registrant, or a security holder of the Registrant. F2 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 01:48 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 4,000 | $1.91 | $7,640.00 |
DisclosureSEC source: 0001437749-18-005273 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,590,608 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.90 to $1.94 for the March 21, 2018 purchases and $1.85 to $1.90 for the March 22, 2018 purchases; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the Registrant, or a security holder of the Registrant. F2 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| June 15, 2017 Filed Aug 25, 2017 21:47 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantDirector Stock Option (right to buy) · Derivative | 156,583 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-17-015345 · rdgdoc.xml · derivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,583 Underlying: Common Stock · 156,583 shares Expires 2027-06-15 F1 · derivative.exercise_date: One hundred percent of the shares subject to the option vest and become exercisable on the one year anniversary of the date of grant. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 22:45 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 100,000 | $0.64 | $64,150.00 |
DisclosureSEC source: 0001437749-17-003689 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,916,171 F1 · ownership.nature: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are sole members and managers. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 23:39 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantDirector Stock Option (right to buy) · Derivative | 267,000 | $0.00 Strike: $0.92 | $0.00 |
DisclosureSEC source: 0001437749-17-000791 · rdgdoc.xml · derivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,000 Underlying: Common Stock · 267,000 shares Expires 2027-01-13 F1 · derivative.exercise_date: The option vests and becomes exercisable as to one-third of the shares on January 13, 2018 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 22:56 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 10,000 | $0.82 | $8,228.00 |
DisclosureSEC source: 0001437749-17-000473 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 31,039,310 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.818 to $0.83 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| December 22, 2016 Filed Dec 28, 2016 02:08 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 72,600 | $0.51 | $37,026.00 |
DisclosureSEC source: 0001437749-16-043819 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 31,029,310 F1 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees. Read SEC document |
| November 01, 2016 Filed Dec 28, 2016 02:07 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 100,000 | $0.16 | $16,410.00 |
DisclosureSEC source: 0001437749-16-043818 · rdgdoc.xml · nonDerivative · entry 1 STERTZER SIMON H · CIK 0001031689 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,816,171 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.1620 to $0.1650 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are sole members and managers. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.